Septerna, Inc. (SEPN)
41.86
-6.70
(-13.80%)
USD |
NASDAQ |
Nov 12, 16:00
41.27
-0.59
(-1.41%)
After-Hours: 20:00
Septerna EPS Diluted (Quarterly) : -0.5668 for Sept. 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -0.5668 |
| June 30, 2026 | -0.2894 |
| March 31, 2026 | -0.193 |
| December 31, 2025 | -0.2409 |
| September 30, 2025 | 0.1792 |
| June 30, 2025 | -0.5624 |
| March 31, 2025 | -0.4888 |
| Date | Value |
|---|---|
| December 31, 2024 | -0.6382 |
| September 30, 2024 | -0.4622 |
| June 30, 2024 | -0.3703 |
| March 31, 2024 | -0.319 |
| December 31, 2023 | 0.7447 |
| September 30, 2023 | -0.2465 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Cocrystal Pharma, Inc. | -0.2295 |
| CNBX Pharmaceuticals, Inc. | -0.0001 |
| Arvinas, Inc. | -0.8242 |
| Fulcrum Therapeutics, Inc. | -0.3433 |
| Definium Therapeutics, Inc. | -0.3749 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -26.59M |
| Revenue (Quarterly) | 18.88M |
| Total Expenses (Quarterly) | 45.47M |
| Enterprise Value | 1.528B |
| Gross Profit Margin (Quarterly) | 97.91% |
| Profit Margin (Quarterly) | -140.8% |
| Earnings Yield | -3.08% |
| Normalized Earnings Yield | -3.082 |